Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by Gilbert90on Jul 13, 2019 7:59am
107 Views
Post# 29916532

Bottom line

Bottom lineShare dilution.  To buy LDS TCAN would have to dilute again and shares dilution isn't so ggod for ahreholders.  Just look at ICC cannabis (

TransCanna will buy all of LDS at a price equal to the greater of $51.6 million payable in TCAN shares, or the amount resulting from a fixed exchange ratio of one TCAN shares for every 10 LDS common shares.

Given the purchase price of $51.6 million, TCAN is paying a 17% premium to market (LDS’s market cap is currently $44 million).

Since it is an all-share deal, if TCAN share price falls, it will have to issue more shares in order to close the acquisition.

SInce June 30th TCAN went down from 4,12 to 2,24$  Since jul 08 (TCAN deal with Goodfellas group at 520 000$) S.P. went from 3,24 to 2,24$

TCAN is for me just another ICC International Cannabis Company (WRLD-U) buying and buying with shares dilution.  So at the end the compagny shares are worth nothing.

WRLD was at 0,91 $ on oct 9 2018 now S.P. is at 0,145$


Bullboard Posts